Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang, Wentao Li, Dubravka Drabek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay, Chek Meng Poh, Laurent Rénia, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 6, pp. 363-374
Open Access | Times Cited: 4293
Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1654
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Melika Lotfi, Michael R. Hamblin, Nima Rezaei
Clinica Chimica Acta (2020) Vol. 508, pp. 254-266
Open Access | Times Cited: 985
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications
Fan Wu, Aojie Wang, Mei Liu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 688
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
Janko Nikolich‐Žugich, Kenneth S. Knox, Carlos Tafich Rios, et al.
GeroScience (2020) Vol. 42, Iss. 2, pp. 505-514
Open Access | Times Cited: 580
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2
Austin Nguyen, Julianne K. David, Sean K. Maden, et al.
Journal of Virology (2020) Vol. 94, Iss. 13
Open Access | Times Cited: 525
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2
Bette Korber, WM Fischer, S. Gnanakaran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 524
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Alexandra C. Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell (2020) Vol. 183, Iss. 5, pp. 1367-1382.e17
Open Access | Times Cited: 497
COVID-19 infection and rheumatoid arthritis: Faraway, so close!
Ennio Giulio Favalli, Francesca Ingegnoli, Orazio De Lucia, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 5, pp. 102523-102523
Open Access | Times Cited: 465
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2022) Vol. 399, Iss. 10325, pp. 665-676
Open Access | Times Cited: 354
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
Xiangyu Chen, Li Ren, Zhiwei Pan, et al.
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 6, pp. 647-649
Open Access | Times Cited: 353
COVID-19 and the Immune System
Jan Pačes, Zuzana Střížová, Daniel Smrž, et al.
Physiological Research (2020), pp. 379-388
Open Access | Times Cited: 319
COVID-19 Pandemic: Prevention and Protection Measures to Be Adopted at the Workplace
Luigi Cirrincione, Fulvio Plescia, Caterina Ledda, et al.
Sustainability (2020) Vol. 12, Iss. 9, pp. 3603-3603
Open Access | Times Cited: 308
Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control
Cheryl Yi‐Pin Lee, Raymond Tzer Pin Lin, Laurent Rénia, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 275
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Prasun K. Datta, Fengming Liu, Tracy Fischer, et al.
Theranostics (2020) Vol. 10, Iss. 16, pp. 7448-7464
Open Access | Times Cited: 239
A simple protein-based surrogate neutralization assay for SARS-CoV-2
Kento T. Abe, Zhijie Li, Reuben Samson, et al.
JCI Insight (2020) Vol. 5, Iss. 19
Open Access | Times Cited: 224
Coronavirus: Impact on Stock Prices and Growth Expectations
Niels Joachim Gormsen, Ralph S. J. Koijen
(2020)
Open Access | Times Cited: 202
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options
Shalki Choudhary, Kajal Sharma, Om Silakari
Microbial Pathogenesis (2020) Vol. 150, pp. 104673-104673
Open Access | Times Cited: 193
Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
Tuğba Kiliç, Ralph Weissleder, Hakho Lee
iScience (2020) Vol. 23, Iss. 8, pp. 101406-101406
Open Access | Times Cited: 189
Stock Market Response during COVID-19 Lockdown Period in India: An Event Study
Mohammad Noor Alam, Md Shabbir Alam, Kavita Chavali
Journal of Asian Finance Economics and Business (2020) Vol. 7, Iss. 7, pp. 131-137
Open Access | Times Cited: 183
Patient-derived mutations impact pathogenicity of SARS-CoV-2
Hang‐Ping Yao, Xiangyun Lu, Qiong Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 171
Monoclonal antibody as a potential anti-COVID-19
Leila Jahanshahlu, Nima Rezaei
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110337-110337
Open Access | Times Cited: 163
Treatment for emerging viruses: Convalescent plasma and COVID-19
Bethany Brown, Jeffrey McCullough
Transfusion and Apheresis Science (2020) Vol. 59, Iss. 3, pp. 102790-102790
Open Access | Times Cited: 160
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
Amene Saghazadeh, Nima Rezaei
International Immunopharmacology (2020) Vol. 84, pp. 106560-106560
Open Access | Times Cited: 157
COVID-19: Progress in diagnostics, therapy and vaccination
Xue Liu, Chao Liu, Gang Liu, et al.
Theranostics (2020) Vol. 10, Iss. 17, pp. 7821-7835
Open Access | Times Cited: 148
Page 1 - Next Page

Scroll to top